REAL-WORLD TREATMENT PATTERNS (TXP) AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH NONMETASTATIC CASTRATIONRESISTANT PROSTATE CANCER (NMCRPC) AND METASTATIC HORMONE-SENSITIVEPROSTATE CANCER (MHSPC) IN CHINA
作者全名："Wang, Y.; Liu, C.; Liu, C.; Lu, Y.; Ban, L.; Niu, Y.; Udayachalerm, S."
作者地址："[Wang, Y.; Niu, Y.] Tianjin Med Univ, Hosp 2, Tianjin, Peoples R China; [Liu, C.] Southern Med Univ, Zhujiang Hosp, Guangzhou, Peoples R China; [Liu, C.] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Lu, Y.] Astellas Pharma, Shanghai, Peoples R China; [Ban, L.] Evidera, Beijing, Peoples R China; [Udayachalerm, S.] Evidera, Waltham, MA USA"
通信作者：
来源：VALUE IN HEALTH
ESI学科分类：PHARMACOLOGY & TOXICOLOGY
WOS号：WOS:001031473302508
JCR分区：Q1
影响因子：4.9
年份：2023
卷号：26
期号：6
开始页：S403
结束页：S404
文献类型：Meeting Abstract
关键词：
摘要：
基金机构：
基金资助正文：
